MS - Timely Progression to Natalizumab for greatest possible Benefit

被引：0
|
作者：
不详
机构：
来源：
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2013年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [31] Monoclonal antibodies for MS therapy: natalizumab
    Polman, C. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 2 - 2
  • [32] Natalizumab in MS: JC antibody index
    W. Fung
    N. P. Robertson
    Journal of Neurology, 2015, 262 : 492 - 494
  • [33] Natalizumab efficacy on cognitive impairment in MS
    Mattioli, F.
    Stampatori, C.
    Bellomi, F.
    Capra, R.
    NEUROLOGICAL SCIENCES, 2011, 31 : S321 - S323
  • [34] The return of natalizumab: weighing benefit against risk
    Goodin, D
    LANCET NEUROLOGY, 2006, 5 (05): : 375 - 377
  • [35] QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB
    Steiner, Israel
    NEUROLOGY, 2009, 72 (20) : 1791 - 1791
  • [36] L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
    Schwab, Nicholas
    Schneider-Hohendorf, Tilman
    Posevitz, Vilmos
    Breuer, Johanna
    Goebel, Kerstin
    Windhagen, Susanne
    Brochet, Bruno
    Vermersch, Patrick
    Lebrun-Frenay, Christine
    Posevitz-Fejfar, Anita
    Capra, Ruggero
    Imberti, Luisa
    Straeten, Vera
    Haas, Juergen
    Wildemann, Brigitte
    Havla, Joachim
    Kuempfel, Tania
    Meinl, Ingrid
    Niessen, Kyle
    Goelz, Susan
    Kleinschnitz, Christoph
    Warnke, Clemens
    Buck, Dorothea
    Gold, Ralf
    Kieseier, Bernd C.
    Meuth, Sven G.
    Foley, John
    Chan, Andrew
    Brassat, David
    Wiendl, Heinz
    NEUROLOGY, 2013, 81 (10) : 865 - 871
  • [37] "The greatest possible mastery, the greatest possible self-presence of life" Derrida and the Deconstruction of Sovereignty
    Odello, Laura
    CR-THE NEW CENTENNIAL REVIEW, 2017, 17 (01) : 141 - 162
  • [38] Body mass index as a predictor of MS activity and progression among participants in BENEFIT
    Escobar, Juan Manuel
    Cortes, Marianna
    Edan, Gilles
    Freedman, Mark S.
    Hartung, Hans-Peter
    Montalban, Xavier
    Sandbrink, Rupert
    Radu, E-W
    Barkhof, Frederik
    Wicklein, Eva-Maria
    Kappos, Ludwig
    Ascherio, Alberto
    Munger, Kassandra L.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1277 - 1285
  • [39] The greatest benefit to mankind - A medical history of humanity
    Hollinger, DA
    NEW YORK TIMES BOOK REVIEW, 1998, : 11 - 11
  • [40] The greatest benefit to mankind: A medical history of humanity
    Goodwin, DW
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (12): : 1795 - 1796
12345